SVANOVIR® BLV gp51-Ab is based on the gp51 envelope protein, enabling the detection of antibodies to BLV during early phase of infection. It fulfils the EU standard E05 (EEC directive 88/406/EEC) for serum/plasma and milk, and has been used successfully in BLV eradication and control programmes worldwide.
SVANOVIR® BLV gp51-Ab
The early indicator for bovine leukaemia virus infection (BLV) in cattle
Product Information
| Species | Bovine |
|---|---|
| Samples | Serum, plasma, individual and pools of ≤ 10 Milk, individual and pools of ≤50 |
| Type | Indirect ELISA based on the envelope glycoprotein gp-51 |
| Article number | Samples* | Plates | Format |
|---|---|---|---|
| SV-104884 | 88 | 2 | Strips |
| SV-104885 | 440 | 10 | Plates |
| SV-104886 | 920 | 10 | Strips |
*Samples: Max. number of samples for analysis, wells for kit controls excluded
